top of page

BIOCONVERGENCE & REGULATION

Accelerating Innovation in Therapeutics

A unique online program from Tel Aviv University for biotech and health-tech professionals who want to lead the next generation of medical innovation

Ready to accelerate your innovation?

Gain essential insights into developing next-generation therapeutics.

WHO IS IT FOR

This program is tailored for professionals in biotechnology, life sciences, engineering, digital health, and medicine

Scientists and R&D professionals

Physicians and clinical researchers

Product innovators and entrepreneurs

Regulatory and project managers

Entrepreneurs and BD in health tech

If you are developing novel therapeutics (bioconvergence products) - where biology, technology, data science and AI meet—this program will equip you with the regulatory and scientific foundations to bring them successfully to market.

ABOUT THE PROGRAM

Bioconvergence & Regulation: Accelerating Innovation in Therapeutics is a 4-course online program 

This progam was created by leading scientists at the Gray Faculty of Health and Medical Sciences of Tel Aviv University, in collaboration with Center for TAU Innovation in Education.

Taught by leading experts

Includes interviews with lecturers

Practical case studies & self-assessment quizzes

Certificate from Tel Aviv University 

This program gave me the confidence to lead regulatory strategy in our biotech startup.

  Dr. Sarah Levine

Regulatory Affairs Lead

THE PROGRAM

This educational program is a series of advanced online courses, designed for scientists in the biotech industry who are driving innovation at the intersection of biology, technology, and regulation.

Gain essential insights into the scientific foundations and regulatory pathways that shape the development of next-generation therapeutics.

THE COURSES

The four courses were designed to complement one another. By taking all four courses you will gain a comprehensive understanding of the process of development and regulation of novel medical technologies.

COURSE 1: 

The Scientific Basis of Future Therapeutics

Discover how life sciences, engineering, and physical sciences merge to shape the future of 

COURSE 3: 

Regulations of Software in Medical Technologies

Dive into the evolving regulations of software, AI/ML and generative AI as they are become part of medical technologies.

COURSE 2: 

Regulatory Pathways for Novel Therapeutics

Gain systematic understanding of the regulatory process of medical technologies

COURSE 4: 

Clinical Trials for Bioconvergence Products

study the principles and requirements of successful clinical trials, for products' approval

MEET THE EXPERTS

The program, led by Dr. Michal Roll and Prof. Noam Shomron, bridges two worlds that rarely meet — science and regulation.

Michal brings deep expertise in health policy, ethics, and regulation, while Noam contributes his experience as a genomics researcher, entrepreneur, and innovator in the biotech and digital health space. 
Together, they designed a program that trains the next generation of leaders who can both develop and responsibly implement medical technologies that truly impact patients’ lives.

Dr. Michal Roll and Prof. Noam Shomron

Co-Heads, Master’s Program in Development and Regulation of Medical Technologies

Dr. Michal Roll

Dr. Michal Roll

Prof. Noam Shomron

Prof. Noam Shomron

CORE OF LEADING EXPERTS

Michal brings deep expertise in health policy, ethics, and regulation, while Noam contributes his experience as a genomics researcher, 

Prof. Susan Alpert, MD

Prof. Amir Ayali

Dr. Oren Becker

Dr. Yair Benita

Dr. Raanan Cohen

Prof.Ehud Gazit

Dr. Dan Goldstaub

Mr. Jonathan Helfgott

Prof. Osnat Luxenburg

Gil Mati

Prof. Yaakov Nachmias

Adv. Liad shoham

Dr. Hedva Voliovitch, MD

Ms. Rivka Zaibel

Dr. Jacob Atzmon, MD

Dr. Aryeh Batt

Dr. Sayeh Ben-Arieh

Dr. Anat Boehm-Cagan

Dr. Thomas Colonna

Prof. Ravit Geva, MD

Prof. Dror Haratz

Prof. Tali Ilovitsh

Prof. Ben Maoz

Dr. Shai Melcer

Prof. Ronit Satchi-Fainaro

Dr. Christian Tidona

Ms. Ayala Yogev

Dr. Liat Ziegel Ben David

WHY CHOOSE THIS PROGRAM?

Comprehensive understanding of the regulatory process for novel therapeutics

Learn from world- renowned experts in science and regulation

Exclusive interviews with lecturers sharing real-world insights

Self-assessment quizzes and practical case studies

Study at your own pace with academic support and teaching assistants

Earn a certificate from Tel Aviv University

Bonus for students who complete all four course

Participate in a practicum, virtually applying their own product through the stages of development and regulation, with feedback from the course directors.

This program gave me the confidence to lead regulatory strategy in our biotech startup.

  Dr. Sarah Levine

Regulatory Affairs Lead

SCHEDULING & PRICING

Price of the program (all 4 courses)

$7000*

COURSE 1: December 1st, 2025
COURSE 2: January 11th, 2026
COURSE 3: April 12th, 2026
COURSE 4: June 14th, 2026

Each individual course: $2,000

*Registration starts November 30th 2025

SPECIAL OFFER

Personal practicum for students who complete all four courses

You will be able to virtually apply your own product through the stages of development and regulation and receive valuable feedback from the course directors

bottom of page